alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

LI WANG,

Petitioner,

v.
WILLIAM P. BARR, Attorney General,

Respondent. No. 19

- 70531

Agency No. A206

- 340

- 086

MEMORANDUM *

On Petition for Review of an Order of the Board of Immigration Appeals

Submitted December 2 , 2020 * *

Before: WALLACE, CLIFTON, and BRESS, Circuit Judges.

Li Wang
, a native and citizen of China
, petitions for review of the Board of
Immigration Appeals’ order dismissin g her appeal from an immigration judge’s

decision denying her application for asylum, withholding of removal, and relief
under the Convention Against Torture (“CAT”)

. We have jurisdiction under 8

U.S.C. § 1252. We review factual findings for substantial evidence , applying the

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

DEC 9 2020

MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS2 19

- 70531

standards governing adverse credibility determinations created by the REAL ID

Act. Shrestha v. Holder , 590 F.3d 1034, 1039

- 40 (9th Cir. 2010). We deny the

petition for review.

Substantial evidence supports the adverse credibility determination based on
Wang’s omission of her mother’s threat from her original and amended written

asylum application. See id . at 1048 (adverse credibility determination reasonable
under “the totality of circumstances”) ; see also Silva

- Pereira v. Lynch
, 827 F.3d

1176, 1185

- 86 (9th Cir. 2016) (prior omission supported adverse credibility

determination where new allegations were more compelling)

. Wang’s

explanations do not compel a contrary conclusion. See Lata v. INS , 204 F.3d 1241,

1245 (9th Cir. 2000)

. S ubstantial evidence also supports the finding that Wang did

not present corroborative evidence that would otherwise establish her eligibility for

relief. See Garcia v. Holder , 749 F.3d 785, 791 (9th Cir. 2014) (petitioner’s

documentary evidence was in sufficient to independently support claim). Thus, in

the absence of credible testimony, Wang’s asylum and withholding of removal

claims fail. See Farah v. Ashcroft , 348 F.3d 1153, 1156 (9th Cir. 2003).

Finally, s ubstantial evidence supports the BIA ’s denial of Wang’s CAT

claim because it was based on the same evidence found not credible, and Wang
does not point to any other evidence in the record that compels the conclusion that

it is more likely than not s he woul d be tortured by or with the consent or3 19

- 70531

acquiescence of the government if returned to China

. See Shrestha , 590 F.3d at

1048

- 49.

PETITION FOR REVIEW DENIED.
## Contact Information

Bethesda MD20892

hasnisa@mail.nih.gov 

## Media Resources

LCTU-headshot-hasni.jpg

## Summary

Dr. Sarfaraz Hasni joined NIAMS in 2009 after completing his fellowship training in Clinical Rheumatology from State University of New York at Stony Brook. After joining NIAMS he completed the NIH-Duke Masters in Clinical Research Program. His research interest in lupus is focused on new biomarker discovery and early phase proof of concept clinical trials.

He has established a collaborative network of rheumatologists, nephrologists, physiatrists and other health care providers interested in lupus clinical research in the Metropolitan DC area called DC Lupus Consortium.

Dr. Hasni is also an active clinician and core faculty of the rheumatology fellowship training program at NIAMS. He has initiated several quality improvement processes to provide excellent clinical care to patients with lupus per the current international guidelines.

In 2021, Dr. Hasni received the William G. Coleman Jr., Ph.D., Minority Health and Health Disparities Research Innovation Award for his project Increased Minority Participation in Clinical Research Through Peer–Peer Mentoring Approach which aims to bolster the participation and representation of racial/ethnic minority groups in clinical research of systemic lupus erythematosus.

## Scientific Publications

###             Changes in cardiorespiratory function and fatigue following 12 weeks of exercise training in women with systemic lupus erythematosus: a pilot study.        

9(1).

###             Clinical Images: Cardiovascular magnetic resonance to detect and monitor inflammatory myocarditis in systemic lupus erythematosus.        

4(2).

###             Risk Factors for COVID-19 and Rheumatic Disease Flare in a US Cohort of Latino Patients.        

73(7).

###             Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.        

82(10).

###             Brief Report: Deficiency of Complement 1r Subcomponent in Early-Onset Systemic Lupus Erythematosus: The Role of Disease-Modifying Alleles in a Monogenic Disease.        

69(9).

###             Multicenter Systems Analysis of Human Blood Reveals Immature Neutrophils in Males and During Pregnancy.        

198(6).

###             Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.        

68(7).

###             Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis.        

9(2).

###             miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1.        

24(7).

August 2023

Back to Top
<PAGE>


                                                                    Exhibit 10.1





October 12, 2004


Mr. John M. Stropki, Jr.
32620 Shadowbrook Drive
Solon, Ohio  44139

                           RE: Employment and Benefits
                               -----------------------

Dear John:

This letter sets forth certain modifications to your terms of employment and
benefit entitlements, related to your recent appointment as Chief Executive
Officer of Lincoln Electric Holdings, Inc. (the "Company"). All other terms and
conditions of your employment with the Company, not otherwise addressed in this
letter, shall be determined by the Company, through its Compensation and
Executive Development Committee, in accordance with normal practice.

You will continue to participate in The Lincoln Electric Company Supplemental
Executive Retirement Plan (the "SERP"), under the same terms that existed prior
to your appointment as Chief Executive Officer; provided, however, that the
annual benefit limit under the SERP, as it relates to you, will be set at
$500,000. Except as otherwise modified in this paragraph, the terms of the SERP
will govern your benefits under the SERP.

                                           Very truly yours,



                                           /s/ H. S. Runtagh
                                           -------------------------------
                                           Hellene S. Runtagh
                                           Chairperson, Compensation and
                                           Executive Development Committee

ACCEPTED:


/s/ John Stropki
------------------------
John M. Stropki, Jr.


October 12, 2004
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel, Brain and Tissue Bank Repository.                    

*Date:*                         June 24, 2009.                    

*Time:*                         1 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852 (Telephone Conference Call).                    

*Contact Person:*                         Sathasiva B. Kandasamy, PhD, Scientific Review Administrator, Division Of Scientific Review, National Institute of Child Health and Human Development, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892-9304, (301) 435-6680.                         *skandasa@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: May 19, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-12224 Filed 5-22-09; 8:45 am]

BILLING CODE 4140-01-P
#### UNITED STATES of America, Plaintiff-Appellee, v. Alfredo PEREZ-MONTERO, also known as Jose Luis Alfredo, Defendant-Appellant.

No. 05-41626

Conference Calendar.

United States Court of Appeals, Fifth Circuit.

Oct. 24, 2006.

James Lee Turner, Assistant U.S. Attorney, U.S. Attorney’s Office Southern District of Texas, Houston, TX, for Plaintiff-Appellee.

Marjorie A. Meyers, Federal Public Defender, Molly E. Odom, Federal Public Defender’s Office Southern District of Texas, Houston, TX, for Defendant-Appellant.

Before JOLLY, DeMOSS, and STEWART, Circuit Judges.

PER CURIAM: *

Alfredo Perez-Montero appeals following his guilty-plea conviction for being found unlawfully in the United States after deportation, in violation of 8 U.S.C. § 1326. Perez-Montero argues that the district court misapplied the Sentencing Guidelines by characterizing his state felony conviction for possession of cocaine as an “aggravated felony” for purposes of U.S.S.G. § 2L1.2(b)(l)(C). Perezr-Monte-ro’s argument is unavailing in light of circuit precedent. *See United States v. Hi-nojosa-Lopez,*130 F.3d 691, 693-94 (5th Cir.1997). Perez-Montero argues that this circuit’s precedent is inconsistent with *Jerome v. United States,*318 U.S. 101, 63 S.Ct. 483, 87 L.Ed. 640 (1943). Having preceded *Hinojosa-Lopez, Jerome*is not “an intervening Supreme Court case explicitly or implicitly overruling that prior precedent.” *See United States v. Short,*181 F.3d 620, 624 (5th Cir.1999).

Perez-Montero also challenges the constitutionality of § 1326(b) in light of *Apprendi v. New Jersey,*530 U.S. 466, 120 S.Ct. 2348, 147 L.Ed.2d 435 (2000). Perez-Montero’s constitutional challenge is foreclosed by *Almendarez-Torres v. United States,*523 U.S. 224, 235, 118 S.Ct. 1219, 140 L.Ed.2d 350 (1998). Athough Perez-Montero contends that *Almendarez-Torres*was incorrectly decided and that a majority of the Supreme Court would overrule *Almendarez-Torres*in light of *Apprendi,*we have repeatedly rejected such arguments on the basis that *Almendarez-Torres*remains binding. *See United States v. Garza-Lopez,*410 F.3d 268, 276 (5th Cir.), *cert. denied,*- U.S. -, 126 S.Ct. 298, 163 L.Ed.2d 260 (2005). Perez-Montero properly concedes that his argument is foreclosed in light of *Almendarez-Torres*and circuit precedent, but he raises it here to preserve it for further review.

AFFIRMED.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
ex104consultingagreementwith.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing









      Initials:  WF

      Initials:  MMD
















 

            Initials:  WF

            Initials:  MMD
















 

                 Initials:  WF

                 Initials:  MMD












 

            Initials:  WF

            Initials:  MMD












Private & Confidential                                                                                                                                                                                                                                                              Page 5 of 5 

Wilf Ouellette. CEO 

Placement Agent and released on the successful raise of capital. 

Miscellaneous 

a) Company represents there is no existing or pending litigation except as disclosed in writing to Placement Agent and has a continuing duty to notify. 

b) A successful placement grants Placement Agent the right of first refusal for the next capital raise. 

c) Company will prepare and deliver a current capitalization table that accounts for all outstanding securities of the Company. 

This Agreement may be executed in two or more counterparts, including electronically transmitted counterparts, all of which together shall be considered a single instrument. If the foregoing conforms to your understanding. please sign, date and fax a copy of this letter to our attention at + I 212 658 9009 which will constitute a binding agreement. 

Sincerely, 

Internet Capital Markets Corporation 

By:  /s/ March Michael Drimer              

        Marc Michael Drimer, President

AGREED AND ACCEPTED:

Energy Quest, Inc. 


By:  /s/ Wilf Ouellette                     

        Wilf Ouellette, CEO


Initials:  WF

Initials:  MMD

U5 East 57th Street, ll'h Floor s New York, NY10022

+1 212 537 6836 office • +1 212 658 9009 fax

www.internetcapitalmark ets.com
EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection with the Quarterly Report of CNH Holdings  Company,  Inc.
(dba Cistera  Networks) on Form 10-QSB for the period ending September 30, 2004,
as filed with the  Securities  and Exchange  Commission  on the date hereof (the
"Report"), I, Cindy Garr, Interim C.F.O.of the Company,  certify, pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge and belief:

         (1)      the Report fully  complies  with the  requirements  of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      the information  contained in the Report fairly  presents,  in
                  all material respects,  the financial  condition and result of
                  operations of the Company.


/s/    Cindy Garr
Cindy Garr
C.F.O.,
Executive Vice-President of Corporate Development,
and Director
(Principal Financial Officer)


November 12, 2004


A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
has been  provided  to the  Company  and will be  retained  by the  Company  and
furnished to the Securities and Exchange Commission or its staff upon request.
#### The People of the State of New York, Respondent, v Fletcher B. Quiller, Appellant.

Submitted June 28, 2010;

decided August 26, 2010

*791Motion for an extension of the time within which to apply for permission to appeal pursuant to CPL 460.20 granted and motion papers treated as a timely CPL 460.20 application.
SIXTH DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________

Case No. 6D23-2250

Lower Tribunal No. 21-CC-005129

_____________________________

RICHARD GUTIERREZ and LILIANA GUTIERREZ,

Appellants, 

v.

CITIZENS PROPERTY INSURANCE CORPORATION,

Appellee.

_____________________________

Appeal from the Circuit Court for Lee County.

Erik Leontiev, Judge.

May 7, 2024

PER CURIAM.

AFFIRMED.

STARGEL, WHITE and MIZE, JJ., concur.

Erin M. Berger and Melissa A. Giasi, of Giasi Law, P.A., Tampa, for Appellants.

Daniel M. Schwarz and Kara Rockenbach, of Link & Rockenbach, P.A., West Palm 

Beach, for Appellee.

NOT FINAL UNTIL TIME EXPIRES TO FILE MOTION FOR REHEARING 

AND DISPOSITION THEREOF IF TIMELY FILED
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Transportation

###### Maritime Administration 

          - [Docket No. MARAD 2009 0048] 

                    The Maritime Administration plans to dispose of the obsolete vessel SS                     *Pioneer Commander*, which is currently located at its Beaumont Reserve Fleet in Beaumont, Texas. The Maritime Administration, in consultation with the Texas Historical Commission, determined that the vessel is eligible for listing on the National Register of Historic Places due to its role in a pivotal moment in U.S. history; the evacuation of more than 44,000 Americans, Vietnamese military and refugees from South Vietnam in 1975. This operation signaled the close of America's long involvement in Vietnam.                 

The National Defense Authorization Act for Fiscal Year 2004, Section 3512 of Public Law 108-136, authorizes the Maritime Administration to afford qualified public and non-profit organizations the opportunity to obtain, via donation, obsolete ships from the National Defense Reserve Fleet (NDRF) for use as memorials and/or in other non-commercial enterprises. 

                    The Maritime Administration will accept completed donation applications for the SS                     *Pioneer Commander*                     from qualified organizations in accordance with the Ship Donation Program Requirements for a period of 45 days beginning June 1, 2009. For more information visit the Marad Ship Donation Program at                     *http://www.marad.dot.gov*                     or contact Mr. Kevin Smith at 202-366-3798 or via e-mail at                     *kevin.r.smith@dot.gov*.                 

Dated: May 18, 2009. 

By Order of the Maritime Administrator. 

Christine Gurland, 

Acting Secretary, Maritime Administration.

 [FR Doc. E9-12616 Filed 5-29-09; 8:45 am] 

BILLING CODE P
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                         361,362
<SECURITIES>                                         0
<RECEIVABLES>                               21,044,703
<ALLOWANCES>                                 6,100,000
<INVENTORY>                                  3,109,326
<CURRENT-ASSETS>                                     0
<PP&E>                                         830,711
<DEPRECIATION>                                 188,079
<TOTAL-ASSETS>                              25,472,096
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         33
<COMMON>                                           264
<OTHER-SE>                                  (4,809,485)
<TOTAL-LIABILITY-AND-EQUITY>                25,472,096
<SALES>                                      7,363,336
<TOTAL-REVENUES>                             7,363,336
<CGS>                                                0
<TOTAL-COSTS>                               17,353,743
<OTHER-EXPENSES>                               164,270
<LOSS-PROVISION>                             6,780,120
<INTEREST-EXPENSE>                           3,652,000
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (10,154,677)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (10,154,677)
<EPS-PRIMARY>                                    (3.85)
<EPS-DILUTED>                                        0
        

</TABLE>
#### UNITED STATES of AMERICA, Plaintiff-Appellee, v. Alan EASON, Defendant-Appellant.

No. 08-15952

Non-Argument Calendar.

United States Court of Appeals, Eleventh Circuit.

May 7, 2009.

Alan Eason, Jesup, GA, pro se.

Patricia D. Barksdale, Jacksonville, FL, for Plaintiff-Appellee.

*869Before DUBINA, PRYOR and ANDERSON, Circuit Judges.

PER CURIAM:

W. Charles Fletcher, appointed counsel for Alan Eason in this appeal, has moved to withdraw from further representation of the appellant and filed a brief pursuant to *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967). Our independent review of the entire record reveals that counsel’s assessment of the relative merit of the appeal is correct. Because independent examination of the entire record reveals no arguable issues of merit, counsel’s motion to withdraw is GRANTED and Eason’s revocation of supervised release and resulting sentence are AFFIRMED. Eason’s request for appointment of appellate counsel is accordingly DENIED AS MOOT.